{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T13:29:12Z","timestamp":1791379752947,"version":"4.3.3"},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Cervical cancer is one of the common cancers in females. The common method of screening is Pap test which has low sensitivity. Hence, better methods are explored with different biomarkers, of which estimation of P16 protein can be opted in early detection of cervical cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>Seventy cases and seventy controls were considered for the study. Cases were invasive squamous cell carcinoma (SCC) of cervix confirmed by histopathology. Controls were healthy age-matched females. The blood sample of cases and controls was collected in K2 Ethylenediaminetetraacetic acid vacutainer, and the separated plasma was subjected to estimation of P16 protein by quantitative sandwich Enzyme-Linked ImmunoSorbent Assay method. The data were analyzed for the association between p16 protein in plasma in cases and controls.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>The age among cases and controls ranged from 30 to 80 years. The P16 levels among cases ranged from 3.4 to 19.6 ng\/ml with a mean of 7.24 \u00b1 2.35 ng\/ml. The plasma P16 level in controls ranged between 0.9 and 9.7 ng\/ml with mean of 4.1 \u00b1 2.22 ng\/ml. At cutoff more than 4.8 ng\/ml in cases, the sensitivity, specificity, positive predictive value, negative predictive value, and diagnostic accuracy were 92.86%, 72.86%, 77.4%, 91.1%, and 82.86%, respectively. The specificity increased with increase in plasma p16 levels. The P16 levels were maximum in stage IV disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>This was a pilot study to detect the plasma p16INK4a levels in SCC of cervix. The levels of plasma p16 protein between 3.9 and 5 ng\/ml can be considered as the range for the test to be positive. In clinically suspected cases of cervical cancer, levels more than 4.8 ng\/ml can be considered for the diagnosis as point of care test.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jcrt.jcrt_1290_20","type":"journal-article","created":{"date-parts":[[2023,1,27]],"date-time":"2023-01-27T10:31:54Z","timestamp":1674815514000},"page":"152-157","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Evaluation of enzyme-linked immunosorbent assay plasma p16INK4a protein in squamous cell carcinoma in uterine cervix: A case\u2013control study"],"prefix":"10.4103","volume":"18","author":[{"given":"Kalyani","family":"Raju","sequence":"first","affiliation":[{"name":"Department of Pathology, Sri Devaraj Urs Medical College, Sri Devaraj Urs Academy of Higher Education and research, Kolar, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. V.","family":"Raghuveer","sequence":"additional","affiliation":[{"name":"Department of Pathology, Sri Devaraj Urs Medical College, Sri Devaraj Urs Academy of Higher Education and research, Kolar, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. R.","family":"Sheela","sequence":"additional","affiliation":[{"name":"Department of Obstetrics & Gynecology, Sri Devaraj Urs Medical College, Sri Devaraj Urs Academy of Higher Education and research, Kolar, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arvind","family":"Natarajan","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Sri Devaraj Urs Medical College, Sri Devaraj Urs Academy of Higher Education and research, Kolar, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. V.","family":"Jagadish","sequence":"additional","affiliation":[{"name":"Department of Cell biology & Molecular Genetics, Sri Devaraj Urs Medical College, Sri Devaraj Urs Academy of Higher Education and research, Kolar, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. N.","family":"Sunil","sequence":"additional","affiliation":[{"name":"Department of Community Medicine, Sri Devaraj Urs Medical College, Sri Devaraj Urs Academy of Higher Education and research, Kolar, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Sharat","sequence":"additional","affiliation":[{"name":"Department of Cell biology & Molecular Genetics, Sri Devaraj Urs Medical College, Sri Devaraj Urs Academy of Higher Education and research, Kolar, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,3,30]]},"reference":[{"key":"R1-20250510","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1186\/s12885-020-07161-0","article-title":"Efficient mutation screening for cervical cancers from circulating tumor DNA in blood","volume":"20","author":"Lee","year":"2020","journal-title":"BMC Cancer"},{"key":"R2-20250510","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/ijc.1174","article-title":"Overexpression of p16(INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri","volume":"92","author":"Klaes","year":"2001","journal-title":"Int J Cancer"},{"key":"R3-20250510","doi-asserted-by":"crossref","first-page":"104","DOI":"10.4103\/0974-2727.199630","article-title":"Role of p16\/INK4a and Ki-67 as specific biomarkers for cervical intraepithelial neoplasia: An institutional study","volume":"9","author":"Hebbar","year":"2017","journal-title":"J Lab Physicians"},{"key":"R4-20250510","doi-asserted-by":"crossref","first-page":"7","DOI":"10.4103\/0377-4929.59174","article-title":"Protein P 16INK4A expression in cervical intraepithelial neoplasia and invasive squamous cell carcinoma of uterine cervix","volume":"53","author":"Gupta","year":"2010","journal-title":"Indian J Pathol Microbiol"},{"key":"R5-20250510","doi-asserted-by":"crossref","first-page":"e106384","DOI":"10.1371\/journal.pone.0106384","article-title":"Prognostic significance of overexpressed p16INK4a in patients with cervical cancer: A meta-analysis","volume":"9","author":"Lin","year":"2014","journal-title":"PLoS One"},{"key":"R6-20250510","doi-asserted-by":"crossref","first-page":"121","DOI":"10.15430\/JCP.2016.21.2.121","article-title":"Human papillomavirus genotyping and p16INK4a expression in cervical lesions: A combined test to avoid cervical cancer progression","volume":"21","author":"Zouheir","year":"2016","journal-title":"J Cancer Prev"},{"key":"R7-20250510","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1158\/1055-9965.EPI-09-0328","article-title":"Evaluation of an ELISA for p16INK4a as a screening test for cervical cancer","volume":"18","author":"Balasubramanian","year":"2009","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R8-20250510","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1002\/ijc.22612","article-title":"Evaluation of a new p16INK4a ELISA test and a high-risk HPV DNA test for cervical cancer screening: Results from proof-of-concept study","volume":"120","author":"Mao","year":"2007","journal-title":"Int J Cancer"},{"key":"R9-20250510","doi-asserted-by":"crossref","first-page":"e012547","DOI":"10.1136\/bmjopen-2016-012547","article-title":"Performance of p16INK4a ELISA as a primary cervical cancer screening test among a large cohort of HIV-infected women in western Kenya: A 2-year cross-sectional study","volume":"6","author":"Wu","year":"2016","journal-title":"BMJ Open"},{"key":"R11-20250510","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ijgo.2009.02.009","article-title":"Revised FIGO staging for carcinoma of the cervix","volume":"105","author":"Pecorelli","year":"2009","journal-title":"Int J Gynaecol Obstet"},{"key":"R12-20250510","doi-asserted-by":"crossref","first-page":"160","DOI":"10.4103\/0019-509X.63011","article-title":"Cancer profile in the department of pathology of Sri Devaraj Urs Medical College, Kolar: A ten years study","volume":"47","author":"Kalyani","year":"2010","journal-title":"Indian J Cancer"},{"key":"R13-20250510","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1159\/000501355","article-title":"Liquid biopsy: A new tool in oncology","volume":"63","author":"Costa","year":"2019","journal-title":"Acta Cytol"}],"container-title":["Journal of Cancer Research and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.JCRT_1290_20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:38:11Z","timestamp":1787067491000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.JCRT_1290_20"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":12,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/jcrt.jcrt_1290_20","relation":{},"ISSN":["0973-1482","1998-4138"],"issn-type":[{"value":"0973-1482","type":"print"},{"value":"1998-4138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"2020-09-03","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-09-08","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}